Cargando…
Considerations for Amyotrophic Lateral Sclerosis (ALS) Clinical Trial Design
Thoughtful clinical trial design is critical for efficient therapeutic development, particularly in the field of amyotrophic lateral sclerosis (ALS), where trials often aim to detect modest treatment effects among a population with heterogeneous disease progression. Appropriate outcome measure selec...
Autor principal: | Fournier, Christina N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275386/ https://www.ncbi.nlm.nih.gov/pubmed/35819713 http://dx.doi.org/10.1007/s13311-022-01271-2 |
Ejemplares similares
-
Critical design considerations for time-to-event endpoints in amyotrophic lateral sclerosis clinical trials
por: van Eijk, Ruben P A, et al.
Publicado: (2019) -
Considerations on the concept, definition, and diagnosis of amyotrophic lateral sclerosis
por: Xu, Ren-Shi, et al.
Publicado: (2021) -
Urinary biomarkers for amyotrophic lateral sclerosis: candidates, opportunities and considerations
por: Rogers, Mary-Louise, et al.
Publicado: (2023) -
Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS
por: Goyal, Namita A., et al.
Publicado: (2020) -
Improving clinical trial outcomes in amyotrophic lateral sclerosis
por: Kiernan, Matthew C., et al.
Publicado: (2020)